Such patients may be physically and sexually underdeveloped, may have thyroid hypofunction and may have diabetes insipidus. Often not all these features are present, but chiasmal compression is common. Not infrequently, the patients are adult. They may have little or no endocrine disturbance although some pituitary dysfunction, with diabetes insipidus, may be present. In adults suprasellar calcification is not the rule and the sella is often normal. It not infrequently happens that the diagnosis cannot be made with certainty until the craniotomy is performed.
Plain X-rays usually show no enlargement of the sella, but they may show hydrocephalus. If the tumour is cystic, an EMI scan may show a low density lesion. If there is calcification it will show the increased density.
In surgical treatment the tumour is approached subfrontally. It may be cystic, partially cystic or solid. Usually only a partial removal can be achieved and the patient is treated postoperatively with radiotherapy. If the cyst shows a tendency to refill, a tube may be inserted and brought out to the extradural space.
Aneurysms
The vast majority of aneurysms make their presence felt by rupturing and producing a subarachnoid hemorrhage. Those that declare themselves by compression most commonly do so by producing a III nerve palsy. It is not rare, however, for an aneurysm to cause compression of an optic nerve or, less commonly, the optic chiasm.
The commonest aneurysm to do so is one on the internal carotid artery. An infraclinoid aneurysm in the cavernous sinus will compress the III, V and VI cranial nerves, usually before pressing on the optic nerve. More commonly an aneurysm arising from the carotid at the point of origin of the ophthalmic artery causes compression of the optic nerve and of the chiasm. Such aneurysms arise at about the level of the anterior clinoid process and are within the dura. They may thus, at times, rupture and produce intracranial hvmorrhage.
Aneurysms of the anterior communicating artery may on occasions press on the optic chiasm.
Plain X-rays do not usually help. They may occasionally show calcification in the aneurysm. If the aneurysm is large, an EMI scan may show it and it enhances with conray. An arteriogram enables the definite diagnosis to be made.
Occasionally it is possible to excise an aneurysm causing chiasmal compression. Usually this is deemed too hazardous, and common carotid ligation in the neck is performed, especially for aneurysms of the internal carotid. This will usually prevent further deterioration and may produce a striking and gratifying improvement in vision.
Dr H J G Bloom (Royal Marsden Hospital, Fulham Road, London SW3) The Role of Radiotherapy in the Management of Chiasmal Compression Table 1 shows the approximate incidence of lesions occurring in the region of the chiasma. Pituitary tumours make up half the number, craniopharyngiomas a quarter, meningiomas 1O % and gliomas 7 %.
Pituitary Tumours
Chromophobe adenomas: It is established that surgery alone constitutes inadequate treatment for chromophobe adenomas. Although improvement in vision is promptly achieved by decompression, this benefit is not long-lasting because of tumour recurrence in up to 80(90 % of cases.
Much better results are achieved by surgery and postoperative radiotherapy. The advantages of the combined treatment are that surgery can be restricted to a simple and safer intracapsular decompression, and that the recurrence rate of these radiosensitive tumours following such a conservative procedure is greatly reduced by the adjuvant treatment. In this context, the prime aim of postoperative radiotherapy is not to save vision, which is the purpose of surgery, but to prevent tumour recurrence and thereby maintain the benefit of surgery.
Following surgery alone, the five-year recurrence-free rate is generally only about 500% and can be as low as 100%, whereas after surgery and postoperative irradiation it is 80-90 % (Henderson 1939 , Horrax 1958 , Elkington & McKissock 1967 . Although surgery without irradiation is no longer justified for the treatment of chromophobe adenomas, irradiation alone has been used extensively for these tumours, especially in the United States, with surgery held in reserve for radiotherapy failures. The advantage of radiotherapy alone is that an appreciable operative mortality is avoided. This ranges from about 3 % for patients with small tumours to as high as 30 % or 40 % for those with large tumours and suprasellar extensions. In addition, a proportion of Chordoma, epidermoid, dermoid, metastatic, bone tumour 3-10 patients-may become incapacitated postoperatively, due principally to hypothalamic damage. The choice between a combination of surgery and radiotherapy and radiotherapy alone is based on the relative effectiveness of the two approaches, the associated morbidity and mortality, and the need for urgent surgical decompression to save vision. From a review of reported experience, it seems that significant and long-lasting improvement in vision occurs in some 50-60 % of cases treated by irradiation alone, compared with 70-75 % of survivors following surgery and postoperative irradiation (Svien & Colby 1967 , Elkington & McKissock 1967 . Tumour persistence or recurrence after irradiation alone has been reported in up to 30-40% of cases, compared with some 5-10% following the combined treatment (Elkington & McKissock 1967) . More recently, however, , Kramer (1975) and also Bloom (1973) have reported low 5-year recurrence rates of between 7 % and 11 % following radiotherapy alone (Tables 2-4). Treatment results will be influenced by the proportion of favourable and unfavourable cases selected for radiotherapy.
Royal Marsden Hospital results: Our treatment policy, in general, is to recommend surgical decompression and postoperative irradiation. In certain selected cases, irradiation has been the initial treatment and surgery has been held in reserve for failures. The patients selected for radiotherapy alone have fallen into two main categories; (1) favourable cases with small tumours and no visual impairment and (2) unfavourable cases where operation could be hazardous to both life and sight, because of old age and long-standing poor vision. The results of the combined treatment are somewhat better than those following radiotherapy alone with regard to persistent or recurrent tumour, survival rate and quality of life (Tables 4-5 ).
The advantages of initial surgery are: (1) confirmation of diagnosis; (2) pressure on optic chiasma and adjacent brain is promptly relieved;
(3) cystic tumour which would not be expected to respond well to irradiation can be decompressed.
The indications for primary radiotherapy are: (1) when on general medical grounds the operative risk is expected to be high. The tumours tend to be large with long-standing compression of the chiasma and vision is therefore unlikely to recover; remaining sight may deteriorate further or be lost altogether by the surgical procedure. (2) When the tumour is small with little or no visual field involvement. (3) When there is slight to moderate loss of vision in such cases treatment may be started with irradiation and surgery held in reserve for failures. A prospective clinical trial is required to compare the effectiveness of this approach with immediate operation and radiotherapy.
Contraindications for initial radiotherapy may be summarized as follows: (1) rapidly progressive impairment of vision; (2) severe loss of visual acuity as opposed to visual field loss; (3) clinical picture of pituitary apoplexy; (4) marked pallor of the optic discs;. (5) considerable extrasellar extension; (6) cases of doubtful diagnosis.
If initial irradiation is undertaken, it is important to check for signs of continued visual deterioration. In the event of progressive loss of vision the radiotherapist must be ready to suspend his treatment and transfer the case for prompt operation. However, some initial increase in visual loss may be due to a reactionary cedema and this Table 5 Chromophobe adenoma: quality of survival at 5 years Royal Marsden Hospital (Bloom 1973 will subside satisfactorily if treatment is suspended for a few days: steroids may be helpful in controlling this reaction.
Long-standing relief of chiasmal compression and freedom from tumour recurrence following radiotherapy for pituitary adenomas is related to dosage, far better results being achieved with 4000-5000 rad, compared with-p000-3000 rad (Horrax 1958 . Maximum improvement in vision following irradiation without prior surgical decompression may not be achieved for two or three years.
Invasive Pituitary Tumours
Pituitary tumours occasionally show marked cellular pleomorphism, many mitoses, and invasive features, and should then be regarded as malignant. Metastases may occur in the subarachnoid space and also via the bloodstream, mainly to the liver. The majority of these tumours are endocrinologically inactive or hypoactive, but some are associated with Cushing's syndrome and a few with acromegaly. Severe chiasmal involvement may occur. Attempts to extirpate large tumours carry a high mortality and operation should be limited to simple decompression followed by radical external beam therapy to a larger volume than would generally be used for ordinary pituitary tumours. A dose of 5000-5500 rad in 6-7 weeks is given. The prognosis is grave but not hopeless (Richmond 1958) .
Pituitary Apoplexy
In cases of pituitary apoplexy urgent decompression is required under steriod cover. Some neurosurgeons consider that in such cases post-operative irradiation is contraindicated. There is no evidence to support this view and radiotherapy is recommended in all such cases following recovery from craniotomy.
Radiotherapy Technique
Unlike the treatment required for cerebral gliomas, radiotherapy for pituitary tumours is generally given to a small volume and restricted to the obvious limits of the tumour. Accurate localization is essential and requires air studies or an EMI scan to define the tumour limits, especially in suprasellar extension.
We use a three-wedge-field technique (each 4-5 cm2) with megavoltage equipment (Bloom 1973) . A dose of 4000-4500 rad is delivered in 5-6 weeks and this is adequate to control the majority of chromophobe adenomas without undue risk to normal tissues, including the hypothalamus, which appears to be among the more radiosensitive regions of the central nervous system. Some authors give larger doses or the same dose in a shorter time, and both are associated with an increased risk to the hypothalamus. The minimum dose reported as producing brain necrosis following irradiation for pituitary tumours is 4500 rad in four weeks (Crompton & Leyton 1961) .
Acromegaly
The principal aim of treatment is not so much to reduce tumour mass as to decrease excessive endocrine activity. The latter if uncontrolled is likely to reduce the life-span because of cardiovascular or cerebrovascular disease. In one series, 90O% of cases died before the age of 60 (Evans et al. 1966) .
Although pituitary tumours associated with acromegaly may be quite large and involve the chiasma and hypothalamus, the majority, unlike chromophobe adenomas, do not constitute a threat to vision.
Pituitary tumours in acromegaly are less radiosensitive than chromophobe adenomas. Although external beam therapy may undoubtedly reduce tumour mass and relieve pressure on the chiasma, improve symptoms and even reduce soft tissue bulk, it is doubtful whether this type of treatment reduces growth hormone levels significantly and permanently. It seems that if good health is to be maintained in acromegalic patients, a permanent fall in growth hormone levels to less than 15 ng/ml must be achieved. It is generally believed that this can only be brought about by those methods of treatment which are associated with considerable, if not total, destruction of the pituitary tumour and gland, namely, surgical hypophysectomy, interstitial irradiation (e.g. with radioactive yttrium rods) and high energy, heavy particle beam irradiation using, for example, protons (Bloom 1973) .
On the other hand, evidence is now accumulating that external beam therapy, using doses in the acceptable range of 4500-5000 rad in 5-6 weeks, can bring about a reduction in growth hormone levels to normal or near normal values provided sufficient time is allowed for this to occur, that is, up to 1-2 years (Table 6 ) ( Lawrence 1971 , Kramer 1975 .
A successful result by external beam irradiation has been reported in 75 % of cases (Kramer 1975 and is perhaps more likely to occur in patients with milder symptoms, small tumours and not excessively high growth hormone levels. It appears that patients with a large sella volume, high growth hormone levels (> 50 ng/ml) and severe glucose intolerance have less chance of a satisfactory response, even to cryohypophysectomy (Levin 1975) . It is interesting that in such failed surgical cases, have reported that subsequent radiotherapy (5000 rad in 5 weeks) has been successful in lowering per- Table 6 Acromegaly: growth hormone levels before and after radio-therapy After Results at the Royal Marsden Hospital: Among 46 cases ofacromegaly, 37 received external megavoltage beam therapy, 4 had a combination of surgery and postoperative irradiation, and 5 were treated by interstitial techniques. The 10-year survival rate was 88.50% compared with an expected figure of 93 % for people of similar age and sex distribution (Table 7) . A more prolonged follow up, with longterm assessment of quality of survival and with growth hormone assays, is required fully to evaluate these results. At present the weight of opinion is in favour of more intensive treatment for acromegaly than is possible by standard external beam therapy in order to obtain a substantial and prolonged reduction in plasma growth hormone levels and thereby attain the maximum improvement in general health and longevity (Wright et al. 1970 ). The case for or against external beam therapy is not yet proven: however, evidence is accumulating that growth hormone levels may return to normal following this treatment, provided that two or more years are allowed for this change to take place. Whether this delay is harmful to the patient with diabetes and cardiomyopathy is not yet known. External beam therapy has the double advantage over surgical techniques in carrying a minimal morbidity and of being selective in action in reducing growth hormone production without precipitating adrenal and thyroid hypofunction.
Large tumours with extra-sellar extension should be treated by decompression and postoperative external beam irradiation. Mild elderly cases may be treated in the first instance by external beam therapy alone. Moderate to small, very active tumours can best be treated by interstitial irradiation or by a combination of surgery and interstitial techniques. To compare the value of external beam therapy with other methods of treatment for acromegaly will require cooperative controlled trials. It seems that the same treatment may not necessarily be ideal for all cases and that Section of Ophthalmologya clinical, radiological and biochemical criteria must all be taken into consideration.
Cushing's Syndrome Cushing's syndrome is generally associated with a hyperactive but small gland so that the question of chiasmal compression does not arise. Occasionally, a chromophobe adenoma or carcinoma is present and then surgery combined with postoperative irradiation is required.
Craniopharyngioma
Craniopharyngiomas are the second most common tumours of the intra-and supra-sellar region and constitute some 2-40% of all intracranial tumours, and approximately 80% of all such tumours in children. These tumours may present at any age, but about 50 % occur below the age of 20.
The tumour usually consists of a mixture of solid and cystic elements but may be wholly cystic. It generally forms a smooth, well encapsulated mass lying above the pituitary which exerts pressure on adjacent structures including the chiasma, the floor of the third ventricle and the pituitary by virtue of increasing accumulation of secretion and debris. Sometimes marked cellular proliferation of the tumour occurs, leading to direct invasion of the base of the brain.
Clinicalfeatures: In adults the principal presenting features are visual loss, endocrine insufficiency and mental changes. In children raised intracranial pressure due to obstruction of the foramen of Monro is commonly present, together with severe endocrine insufficiency and reduced visual fields and acuity. Obesity and impaired growth occur and may lead to Fr6hlich's syndrome; rarely, precocious puberty is present.
Diagnosis: A plain X-ray of skull is often diagnostic, showing changes in the sella and, classically, supraor intra-sellar calcification in 80 % of children, but in only 40 % of adults. Air studies reveal indentation of the floor of the Illrd ventricle and an EMI scan helps to define tumour limits.
Treatment: Developmental tumours are usually slow-growing, benign lesions for which surgical removal would appear to be the only feasible treatment. Total excision of craniopharyngiomas, however, is difficult and often impossible without inflicting serious local damage to the base of the brain. An operative mortality of 30 40 % has been reported by most major neurosurgical units. Furthermore, even when complete excision has apparently been achieved, a substantial proportion of such cases will die from recurrence, apart from the high incidence of serious postoperative sequele.
Because of the operative hazards, some authors have adopted a more conservative surgical approach to this tumour, but following aspiration or only partial excision, recurrence will occur in a high proportion of patients. The overall results of surgical treatment for craniopharyngiomas are generally poor. Of 108 cases treated by different procedures at
Olivecrona's clinic, only 20 % were still alive and well 2-31 years after operation: the combined mortality from operation or tumour was 650% (Svolos 1969) . Carpenter et al. (1937) were the first to draw attention to the possible value of radiotherapy for these tumours. The first detailed study using modern irradiation techniques was reported from the Royal Marsden Hospital by Kramer et al. (1961) .
Royal Marsden experience: Our treatment policy for craniopharyngiomas over the past 25 years has been conservative surgery combined with radical postoperative radiotherapy (Bloom 1973) . Between 1950 and 1971 a total of 122 patients with this tumour were referred to this Hospital for irradiation: 112 were new cases and 10 were recurrent following previous surgery; 107 of the 112 new patients received radiotherapy, 104 by external beam and 3 by interstitial techniques. Of the 99 cases in whom primary surgery was carried out, the procedure was conservative in 85 (86 %); in only 14 cases was radical excision attempted, being accomplished in only 3 (Table 8 ).
The overall 3-, 5-and 10-year survival rates for previously untreated tumours in children and adults are shown in Table 9 . More recent cases treated by a uniform technique and dosage with 6 MV X-rays are presented in Table 10 (Bloom & Harmer 1976 ).
The quality of survival after treatment can generally be judged by results at two years. At that time 900% of our cases had no significant neurological or mental disability, and vision was good or useful in 83 % (Table 11) . Regular follow up of both children and adults treated for craniopharyngioma is essential, in order to detect recurrence and endocrine deficiences as early as possible. A cooperative approach is required for the management of these cases and our team includes physicians interested in endocrinology.
The results for conservative surgery and radical radiotherapy for craniopharyngiomas now constitute more than a challenge to radical surgery. Furthermore, the conservative approach is applicable in virtually all cases, whilst attempts at radical excision are necessarily restricted to a selected few. Suprasellar Germinoma ('Ectopic Pinealoma') This is a tumour entity characterized by the presence of two types of cell, one a large pineal cell with prominent nucleoli and eosinophilic cytoplasm, and the other indistinguishable from a lymphocyte. The tumours belong to the same class as the germinomas of the testis, abdomen, mediastinum and pineal region.
Patients present mainly between the ages of 5 and 25 with visual disturbance, features of hypopituitarism, diabetes insipidus and sometimes pre-cocious puberty (Rubin & Kramer 1965 , Camins & Mount 1974 .
The tumours are usually situated inferior and posterior to the optic chiasma and infiltrate the chiasma, infundibulum and hypothalamus and extend along the optic nerves. They may seed in the CSF and become implanted in various ventricular and meningeal sites. Of 58 collected cases 10 developed spinal subarachnoid metastases, an incidence of 17 % (Camins & Mount 1974) .
The management of these cases should involve exploratory craniotomy for investigation and biopsy with decompression. Attempts at radical removal of the tumour are unnecessary since surgery alone has not cured such cases and the tumour is extremely radiosensitive. Radiotherapy is therefore the principal treatment and has given good results. Whole cerebrospinal axis radiation is recommended to 3000 rad in approximately 5 weeks, with a booster dose to raise the intracranial tumour region to a total of 4500-5000 rad. A 5-year survival rate of about 70 % is to be expected.
Meningiomas
Meningiomas constitute about 13-180% of all intracranial tumours and generally appear in middle and later life. Those causing chiasmal compression arise from the region of the tuberculum sellae and can reach a considerable size, displacing the chiasma upwards. Surgical removal is often incomplete and there is a high risk of recurrence from remnants at the site of attachment.
It is widely believed that these benign connective-tissue tumours are radioresistant, and that irradiation has no part to play in their control. The available evidence, however, does not support this view. Very large inoperable meningiomas have been seen slowly to decrease in size following radiotherapy, with clinical improvement lasting for several years. In the case of residual tumour after surgery, experience suggests that recurrence can be reduced or at least delayed by postoperative radiotherapy. Wara et al. (1975) have recently reported their experience in 176 patients of whom 45 (25 %) were followed for 10-20 years. The possible benefit of postoperative irradiation is seen when surgical resection has been incomplete (Table 12) . Royal Marsden Hospital results: A total of 160 cases of intracranial meningioma have been referred to the Royal Marsden Hospital for radiotherapy between 1959 and 1973, and of these, 30 were recurrent. The recurrence-free results, among 37 cases following radiotherapy as the sole treatment or after only limited surgery, are comparable to those in 65 cases for postoperative irradiation after total or subtotal tumour removal (Tables 13, 14) .
The value of radiotherapy is perhaps best seen in 35 new or recurrent cases unsuitable for surgery and treated by irradiation alone. Objective improvement was seen in 15 (430%) including five patients with impaired visual fields. In 5 of the 15 cases, however, recurrences occurred within 1-6 years of treatment; the condition remained stationary in a further 14 cases for 3-15 years or more, and in only 5 of the 35 did the clinical condition continue to deteriorate in spite of irradiation (Bloom & Sandland 1976, in preparation) . King et al. (1966) , in a small number of cases, found a substantial increase in the recurrence-free interval in patients with the 'angioblastic' type of meningioma and with meningeal sarcomas following postoperative radiotherapy, compared with those treated by operation alone. In this study there was no apparent benefit from the combined treatment in cases with typical meningioma.
Although the value of radiotherapy in meningiomas is difficult to assess because of the slow growth of the tumours, the long survival of many patients following incomplete extirpation, and the influence of tumour site on the clinical picture, it would seem that postoperative irradiation can be of benefit and should be offered to patients in whom there is a substantial risk of recurrence, evidenced by infiltration, unfavourable histological criteria, or gross residual disease.
Gliomas of the Floor of the Third Ventricle and Hypothalamus These tumours are generally astrocytomas of low or high grade malignancy and make up about 7 % of all tumours affecting the chiasmal region. They are generally inoperable and therefore treatment is by irradiation alone. Some reported results following such treatment are surprisingly good: for example, in a series of 32 children with tumours of Hospital, 77 % (of 26 cases) were alive at 5 years, and 50 % (of 14 cases) at 10 years (Bloom & Walsh 1975 ).
Metastases
The pituitary may be the seat of blood-borne metastases from various primary sites, especially the breast. This may be an incidental finding at hypophysectomy or at autopsy. However, in some cases it may produce the features of a rapidly increasing pituitary tumour with progressive loss of vision. Here prompt treatment must be undertaken to preserve sight and the most reliable and practical method is by irradiation, with steroids to reduce local cedema. A dose of 3500-4000 rad in 4-41 weeks is generally sufficient. If the vision is deteriorating rapidly or there is doubt about the nature of the pituitary lesion, prompt operation is indicated.
Late Complications of Radiotherapy
The normal adult pituitary gland and the optic chiasma are relatively radioresistant and no serious functional disturbance is expected to follow radical external beam therapy in the dose range of 5000-5500 rad in 6-7 weeks which, for example, is used for malignant glial tumours. Recent observations suggest that in the case of children, radiotherapy involving the pituitary-hypothalamic region may result in a reduced output of growth hormone (Shalet et al. 1975) .
A few examples of brain damage following treatment of pituitary tumours and craniopharyngiomas have followed the use of dose/time factors which are no longer considered safe and have been abandoned by most radiotherapists. A major factor in avoiding serious damage to the central nervous system is not to deliver the recommended dose in too short an overall time. A weekly tumour dose of 750-800 rad should not be exceeded. In the case of very young children, we make a reduction in the dose to allow for the possible greater vulnerability of developing brain tissue to irradiation. However, children of 4 or 5 years and' older appear to tolerate the recommended dose for adults (for review see Bloom 1971) .
Malignant tumours, usually fibrosarcomas, have been reported as occurring in the sellar region 5-20 years after treatment for chromophobe or acidophilic adenomas. This serious complication is, fortunately, rare, and most cases have followed multiple-course radiation, a technique long abandoned. The risk of malignant transformation, which occurs far less frequently than operative deaths, is far outweighed by the undisputed overall benefit of radiotherapy for pituitary tumours. With modern radiotherapy techniques and the use of generally accepted dose/time schedules, serious complications following external beam therapy for tumours in the sellar region are exceedingly rare.
